Article info
PDFCongenital heart disease
Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease
- Correspondence to:
Dr Sotiria C Apostolopoulou
Department of Paediatric Cardiology, Onassis Cardiac Surgery Centre, 356 Syngrou Ave, Athens, GR 176 74, Greece; riaposhol.gr
Citation
Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease
Publication history
- Accepted November 29, 2004
- First published March 10, 2005.
Online issue publication
March 15, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Heart